Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼

Tuesday, May 26, 2009

Southwest Oncology Group Trial S9912: Intraperitoneal cisplating and paclitaxel plus IV paclitaxel and PLD as priary chemo of small volume residual OC

"CONCLUSION: Both the overall trial outcome, and specifically the excessively severe systemic toxicity of this regimen would prevent its future development in this exact form."

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.